Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00603187 · ClinicalTrials.gov registry record · Phase 1
ACY-7 Oral Administration of Acyline
A Phase 1 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT00603187 is a Phase 1 study that has completed, run by University of Washington. The registered enrollment target is 4 participants.
The verdict
NCT00603187, a Phase 1 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
We propose oral dosing of gastrointestinal permeation enhancement technology \[GIPET\] enhanced oral acyline at 20 mg everyday for one week to determine the steady-state (multiple-dose) pharmacokinetics of oral acyline in four normal, healthy young men.
Interventions
- DRUG Acyline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00603187
The ClinicalTrials.gov registry entry for NCT00603187 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acyline is the first listed.
NCT00603187 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00603187 about?
NCT00603187 is a clinical study titled "ACY-7 Oral Administration of Acyline". We propose oral dosing of gastrointestinal permeation enhancement technology \[GIPET\] enhanced oral acyline at 20 mg everyday for one week to determine the steady-state (multiple-dose) pharmacokinetics of oral acyline in four normal, healthy young men.
What is the current status of trial NCT00603187?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2008-01. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00603187?
The interventions under investigation include: Acyline (DRUG).
Who is sponsoring clinical trial NCT00603187?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.